A detailed history of Dark Forest Capital Management LP transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Dark Forest Capital Management LP holds 49,376 shares of BCRX stock, worth $373,776. This represents 0.05% of its overall portfolio holdings.

Number of Shares
49,376
Holding current value
$373,776
% of portfolio
0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.41 - $8.69 $316,500 - $429,077
49,376 New
49,376 $375,000
Q3 2022

Nov 14, 2022

BUY
$10.79 - $14.81 $72,228 - $99,138
6,694 Added 17615.79%
6,732 $85,000
Q2 2022

Aug 15, 2022

BUY
$7.89 - $17.88 $299 - $679
38 New
38 $0
Q3 2021

Nov 12, 2021

SELL
$14.21 - $17.65 $27,268 - $33,870
-1,919 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$9.5 - $17.24 $18,230 - $33,083
1,919 New
1,919 $30,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.41B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.